Factor Analysis of Changes in Hemoglobin A1c After 12 Months of Sitagliptin Therapy in Patients With Type 2 Diabetes

BACKGROUND: Sitagliptin, a dipeptidyl peptidase-4 inhibitor, is an effective oral antidiabetic agent as both monotherapy and when combined with insulin. Data from three observational studies performed in patients with type 2 diabetes receiving sitagliptin therapy in the routine clinical setting were...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Med Res
Main Authors: Yuasa, Shouhei, Sato, Kazuyoshi, Takai, Masahiko, Ishikawa, Masashi, Umezawa, Shinichi, Kubota, Akira, Maeda, Hajime, Kanamori, Akira, Miyakawa, Masaaki, Tanaka, Yasushi, Terauchi, Yasuo, Matsuba, Ikuro
Formato: Artigo
Idioma:Inglês
Publicado em: Elmer Press 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4852779/
https://ncbi.nlm.nih.gov/pubmed/27222674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr2540w
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados